CRISPR Therapeutics AG (CRSP)

NASDAQ: CRSP · Real-Time Price · USD

54.92

+0.94 (1.74%)

At close: Jun 26, 2026, 4:00 PM EDT

54.86

-0.06 (-0.11%)

After-hours: Jun 26, 2026, 7:59 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Collaboration Revenue	-	-	35.00M
Collaboration Revenue Growth	-	-	-90.54%
Grant Revenue	3.10M	3.51M	2.31M
Grant Revenue Growth	-11.59%	51.69%	91.87%
Revenue (Other)	1.00M	-	-
Revenue (Total)	4.10M	3.51M	37.31M
Revenue (Total) Growth	16.89%	-90.59%	-89.95%

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Remaining Performance Obligations	12.30M	12.30M	12.30M